Latest Market News

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

BPM Minerals has commenced a significant 6,000m aircore drilling program at its Claw Gold Project in Western Australia, aiming to extend known gold mineralisation along an 8km corridor adjacent to Capricorn Metals' Mount Gibson Gold Project.

Hamelin Gold has identified a significant 500-metre gold anomaly at its Ularring Gold Project using advanced soil sampling technology, setting the stage for a targeted drilling campaign starting in March 2025.

Olympio Metals has entered an Option Agreement to sell its remaining Halls Creek tenements to Clutch Group, enabling a sharper focus on its flagship Dufay Cu-Au Project in Quebec.

Civmec’s 1H FY25 results reveal robust revenue growth and a strong balance sheet, underpinned by a diversified project pipeline and strategic moves into naval shipbuilding and material handling equipment manufacturing.

Civmec Limited reports solid first-half FY25 results with revenue growth and a stable dividend, while navigating margin pressures and advancing strategic projects.

Sipa Resources has completed the acquisition of four advanced gold exploration projects across South Australia and Western Australia, backed by a $1.75 million capital raise and the strategic appointment of industry veteran Stephen Biggins to its board.

Meridian Energy's January 2025 report reveals a sharp drop in national hydro storage and inflows, coinciding with one of the driest Januarys on record and a notable dip in retail sales volumes.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

HealthCo Healthcare & Wellness REIT reported a solid 5% increase in Funds From Operations (FFO) and Distribution Per Unit (DPU) for the first half of FY25, underpinned by stable asset valuations and a robust healthcare portfolio.

Cochlear Limited posted a 5% increase in sales revenue to $1.17 billion for the half year ended December 2024, driven by strong cochlear and acoustic implant growth despite a decline in Services revenue. The company anticipates FY25 underlying net profit at the lower end of guidance amid increased cloud investments and prepares for new product launches.